CLINICAL COURSE AND LONG-TERM PROGNOSIS OF DILATED CARDIOMYOPATHY IN CHILDREN
Keywords:
dilated cardiomyopathy, pediatric cardiology, congestive heart failure, echocardiography, reverse remodeling, long-term survival, left ventricular dysfunction.Abstract
Dilated cardiomyopathy remains one of the most complex and severe myocardial diseases encountered in pediatric cardiology, characterized by left ventricular dilation and profound systolic dysfunction. This condition frequently leads to progressive heart failure, carrying a high burden of morbidity and a significant mortality rate if not diagnosed and managed promptly. The present comprehensive study analyzes the detailed clinical manifestations, echocardiographic evolution, and long-term prognostic outcomes in a specific cohort of forty-eight pediatric patients. These patients were continuously treated and monitored at the Andijan Regional Children's Multidisciplinary Medical Center. The findings emphasize that while standard neurohormonal blockade can induce partial reverse remodeling and symptom relief in a subset of patients, the overall long-term prognosis remains heavily dependent on the baseline severity of ventricular impairment. The study underscores the critical importance of early echocardiographic screening, aggressive pharmacological intervention, and continuous longitudinal monitoring to improve survival rates, prevent sudden cardiac death, and optimize specialized therapeutic strategies for children residing in the Central Asian region.
References
1.Lipshultz, S. E., Law, Y. M., Ashton, R. W., et al. (2019). Executive Summary of the American Heart Association Scientific Statement on Pediatric Cardiomyopathies. Circulation, 140(1), 9-11.
2.Towbin, J. A., Lowe, A. M., Colan, S. D., et al. (2006). Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA, 296(15), 1867-1876.
3.Bowles, N. E., Ni, J., Kearney, D. L., et al. (2003). Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause associated with myocarditis in children and adults. Journal of the American College of Cardiology, 42(3), 466-472.
4.Rosenthal, D., Chrisant, M. R., Edens, E., et al. (2004). International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. The Journal of Heart and Lung Transplantation, 23(12), 1313-1333.
5.Alexander, P. M., Daubeney, P. E., Nugent, A. W., et al. (2013). Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation, 128(18), 2039-2046.
6.Shaddy, R. E., Boucek, M. M., Hsu, D. T., et al. (2007). Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA, 298(10), 1171-1179.
7.Alvarez, J. A., Orav, E. J., Wilkinson, J. D., et al. (2011). Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation, 124(7), 814-823.
8.Everitt, M. D., Sleeper, L. A., Lu, M., et al. (2014). Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Journal of the American College of Cardiology, 63(14), 1405-1413.
9.Lee, T. M., Hsu, D. T., Kantor, P., et al. (2017). Pediatric Cardiomyopathies. Circulation Research, 121(7), 855-873.
10.Kimura, Y., Iida, K., Kuroha, M., et al. (2020). Long-term outcomes and predictors of survival in pediatric dilated cardiomyopathy: A single-center experience. Pediatric Cardiology, 41(5), 1012-1019.
11.Kantor, P. F., Lougheed, J., Dancea, A., et al. (2013). Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Canadian Journal of Cardiology, 29(12), 1535-1552.
12.Pahl, E., Sleeper, L. A., Canter, C. E., et al. (2012). Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. Journal of the American College of Cardiology, 59(6), 607-615.
13.Denfield, S. W., & Webber, S. A. (2014). Restrictive cardiomyopathy in childhood. Heart Failure Clinics, 6(4), 445-452.
14.Kaski, J. P., & Elliott, P. M. (2007). The classification of right ventricular cardiomyopathies in children. Cardiology in the Young, 17(5), 459-467.
15.Jefferies, J. L., & Towbin, J. A. (2010). Dilated cardiomyopathy. The Lancet, 375(9716), 752-762.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal